You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CHRONIC HEPATITIS

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Hepatitis B Trial (Imdusiran (AB-729))

Not yet recruiting
  • Chronic Hepatitis B
  • Imdusiran (AB-729)
  • (no location specified)
Nov 30, 2023

Safety and Biomarkers of Bulevirtide Treatment in Chronic

Recruiting
  • Chronic Hepatitis D
  • Stockholm, Sweden
    Karolinska University Hospital, Department of Infectious Disease
Sep 27, 2023

Chronic Hepatitis B Trial run by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (VIR-2218 and

Not yet recruiting
  • Chronic Hepatitis B
  • VIR-2218 and peginterferon alfa-2a
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 27, 2023

Viral Hepatitis D Relapses Upon Discontinuation of Bulevertide

Recruiting
  • Chronic Hepatitis D
    • Moscow, Russian Federation
      Center of Target Therapy
    Nov 6, 2023

    Tenofovir Disoproxil Fumarate and Entcavir in Treatment of

    Recruiting
    • Chronic Hepatitis b Patients
    • Tenofovir Disoproxil Fumarate and Entcavir
    • Sohag, Egypt
      Sohag University hospitals
    May 22, 2023

    Fibronectin Type ? Domain Containing Protein 5 \ Irsin Gene

    Recruiting
    • Hepatitis B, Chronic
    • genotyping
    • Sohag, Egypt
      Sohag university Hospital
    Sep 4, 2023

    Dynamic Changes of Serum HBV RNA in Chronic Hepatitis B Patients

    Not yet recruiting
    • Chronic Hepatitis B Patients
      • Beijing, Beijing, China
        Beijing Friendship Hospital, Capital Medical University
      Aug 15, 2023

      Chronic Hepatitis D Infection Trial in Changchun (Hepalatide, Hepalatide Placebo)

      Not yet recruiting
      • Chronic Hepatitis D Infection
      • Changchun, China
        The first hospital of Jilin University
      Apr 22, 2023

      Chronic Hepatitis B, Non-alcoholic Fatty Liver Disease Trial in Taipei (exercise)

      Enrolling by invitation
      • Chronic Hepatitis B
      • Non-alcoholic Fatty Liver Disease
      • exercise
      • Taipei, Zhongzheng Dist., Taiwan
        National Taiwan University Hospital
      Jul 13, 2023

      Chronic Hepatitis b Trial (CB06-036, Placebo)

      Not yet recruiting
      • Chronic Hepatitis b
      • (no location specified)
      Apr 12, 2023

      Hepatic Fibrosis on Hepatic Steatosis Using Ultrasound

      Not yet recruiting
      • Hepatic Steatosis
      • +2 more
        • Seoul, Korea, Republic of
          Asan Medical Center
        May 21, 2023

        A Study of Chronic Hepatitis C Patients Treated With SOF/VEL/VOX

        Recruiting
        • Hepatitis C
          • Istanbul, Turkey
            Cerrahpasa Medical Faculty
          Aug 26, 2023

          Chronic Hepatitis Delta Virus Infection Trial (HH-003(20mg/kg), HH-003(10mg/kg), TAF)

          Not yet recruiting
          • Chronic Hepatitis Delta Virus Infection
          • HH-003(20mg/kg)
          • +2 more
          • (no location specified)
          May 7, 2023

          Chronic Hepatitis B Trial (HRS9950 tablets, HRS9950 tablets)

          Not yet recruiting
          • Chronic Hepatitis B
          • HRS9950 tablets
          • HRS9950 placebo tablets
          • (no location specified)
          Jun 7, 2023

          Chronic Hepatitis B Trial in Beijing (TCR-T)

          Active, not recruiting
          • Chronic Hepatitis B
          • TCR-T
          • Beijing, China
            The Fifth Medical Center of PLA General Hospital
          Jun 13, 2023

          Chronic Hepatitis D Infection Trial (Bulevirtide)

          Not yet recruiting
          • Chronic Hepatitis D Infection
          • Bulevirtide
          • (no location specified)
          Jan 30, 2023

          Predict Antiviral Therapy in Gray Zone of Chronic Hepatitis B

          Not yet recruiting
          • Hepatitis B, Chronic
          • Exposure factors
          • (no location specified)
          Sep 10, 2023

          After Long-Term Antiviral Treatment for Chronic Hepatitis B

          Completed
          • Chronic Hepatitis B e Antigen Positive
          • Chronic Hepatitis B e Antigen Negative
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            Jan 26, 2023

            Hepatitis B, Chronic Trial in Jilin (AHB-137 injection, Placebo)

            Recruiting
            • Hepatitis B, Chronic
            • AHB-137 injection
            • Placebo
            • Jilin, China
              The First Hospital of Jilin University
            Nov 2, 2023

            Chronic Hepatitis B Trial in Guangzhou (NrtIs, HH-003, HH-003+NrtIs)

            Active, not recruiting
            • Chronic Hepatitis B
            • Guangzhou, Guangdong, China
              Nanfang Hospital, Southern Medical University
            Apr 20, 2023

            Hepatic Steatosis and Chronic Hepatitis B Virus

            Not yet recruiting
            • Chronic Hepatitis
            • Liver biopsy
            • Sohag, Egypt
              Faculty of medicine
            Dec 28, 2022

            Hepatitis D Trial in Athens (Bulevirtide)

            Recruiting
            • Hepatitis D
            • Athens, Greece
              Department of Gastroenterology, Medical School of National & Kap
            Jun 28, 2023

            COVID-19 Infection and Its Clinical Prognosis in Chronic

            Recruiting
            • Chronic Hepatitis B
            • COVID-19 Infection
            • Beijing, Beijing, China
              Department of Hepatology Division 2, Beijing Ditan Hospital
            Mar 28, 2023

            Protease Inhibitors in Chronic Hepatitis C

            Completed
            • Chronic Hepatitis C
              • Graz, Austria
                Department of Internal Medicine, Medical University of Graz
              Jan 11, 2023

              Metabolic Syndrome on Antiviral Response in People With Chronic

              Not yet recruiting
              • Chronic Hepatitis b
                • (no location specified)
                Jan 21, 2023